Literature DB >> 17437270

Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum.

Pratima Nangia-Makker1, Larry Tait, Malathy P V Shekhar, Eduardo Palomino, Victor Hogan, Marie P Piechocki, Tatsuyoshi Funasaka, Avraham Raz.   

Abstract

Ocimum sp. is a traditionally used medicinal herb, which shows anti-oxidant, anti-carcinogenic, radio-protective and free radical scavenging properties. So far no detailed studies have been reported on its effects on human cancers. Thus, we analyzed its effects on human breast cancer utilizing in vitro and in vivo methodologies. Aqueous extracts were prepared from the mature leaves of Ocimum gratissimum (OG) cultivated devoid of pesticides. Tumor progression and angiogenesis related processes like chemotaxis, proliferation, apoptosis, 3D growth and morphogenesis, angiogenesis and tumor growth were studied in the presence or absence of the extract, and in some experiments a comparison was made with purified commercially available eugenol, apigenin and ursolic acid. Aqueous OG leaf extract inhibits proliferation, migration, anchorage independent growth, 3D growth and morphogenesis and induction of COX-2 protein in breast cancer cells. A comparative analysis with eugenol, apigenin and ursolic acid showed that the inhibitory effects on chemotaxis and 3D morphogenesis of breast cancer cells were specific to OG extract. In addition, OG extracts reduced tumor size and neoangiogenesis in a MCF10 DCIS.com xenograft model of human DCIS. This is the first detailed report showing that OG leaf extract may be of value as a breast cancer preventive and therapeutic agent and might be considered as additional additive in the arsenal of components aimed at combating breast cancer progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437270      PMCID: PMC3613994          DOI: 10.1002/ijc.22733

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  45 in total

Review 1.  Plant-derived phenolic antioxidants.

Authors:  G Duthie; A Crozier
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2000-11       Impact factor: 4.294

2.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.

Authors:  G Bergers; R Brekken; G McMahon; T H Vu; T Itoh; K Tamaki; K Tanzawa; P Thorpe; S Itohara; Z Werb; D Hanahan
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

3.  Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.

Authors:  Edgar S Díaz-Cruz; Charles L Shapiro; Robert W Brueggemeier
Journal:  J Clin Endocrinol Metab       Date:  2005-02-01       Impact factor: 5.958

4.  Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.

Authors:  F Yin; A E Giuliano; R E Law; A J Van Herle
Journal:  Anticancer Res       Date:  2001 Jan-Feb       Impact factor: 2.480

5.  Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells.

Authors:  S Gupta; F Afaq; H Mukhtar
Journal:  Biochem Biophys Res Commun       Date:  2001-10-05       Impact factor: 3.575

Review 6.  Matrix metalloproteinase inhibitors and cancer: trials and tribulations.

Authors:  Lisa M Coussens; Barbara Fingleton; Lynn M Matrisian
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

7.  HER-2/neu status is a determinant of mammary aromatase activity in vivo: evidence for a cyclooxygenase-2-dependent mechanism.

Authors:  Kotha Subbaramaiah; Louise R Howe; Elisa R Port; Edi Brogi; Jack Fishman; Catherine H Liu; Timothy Hla; Clifford Hudis; Andrew J Dannenberg
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

Review 8.  Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.

Authors:  Jeanette A Richards; Trevor A Petrel; Robert W Brueggemeier
Journal:  J Steroid Biochem Mol Biol       Date:  2002-02       Impact factor: 4.292

Review 9.  Pharmacology of oleanolic acid and ursolic acid.

Authors:  J Liu
Journal:  J Ethnopharmacol       Date:  1995-12-01       Impact factor: 4.360

10.  Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.

Authors:  Randall E Harris; Joanne Beebe-Donk; Galal A Alshafie
Journal:  BMC Cancer       Date:  2006-01-30       Impact factor: 4.430

View more
  21 in total

Review 1.  Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer.

Authors:  Huanjie Yang; Q Ping Dou
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

Review 2.  Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review.

Authors:  Prabhat Singh; Raghuvir Singh Tomar; Srikanta Kumar Rath
Journal:  Mol Biol Rep       Date:  2015-06-02       Impact factor: 2.316

3.  Anti-inflammatory, Anti-nociceptive and Total polyphenolic Content of Hydroethanolic Extract of Ocimum gratissimum L. Leaves.

Authors:  A M Ajayi; J K Tanayen; Joc Ezeonwumelu; S Dare; A Okwanachi; B Adzu; O G Ademowo
Journal:  Afr J Med Med Sci       Date:  2014-09

4.  Carnosol, rosemary ingredient, induces apoptosis in adult T-cell leukemia/lymphoma cells via glutathione depletion: proteomic approach using fluorescent two-dimensional differential gel electrophoresis.

Authors:  Yo-ichi Ishida; Masao Yamasaki; Chizuko Yukizaki; Kazuo Nishiyama; Hirohito Tsubouchi; Akihiko Okayama; Hiroaki Kataoka
Journal:  Hum Cell       Date:  2013-12-10       Impact factor: 4.174

5.  Ocimum gratissimum retards breast cancer growth and progression and is a natural inhibitor of matrix metalloproteases.

Authors:  Pratima Nangia-Makker; Tirza Raz; Larry Tait; Malathy P V Shekhar; Hong Li; Vitaly Balan; Hemanckur Makker; Rafael Fridman; Krishnarao Maddipati; Avraham Raz
Journal:  Cancer Biol Ther       Date:  2013-02-04       Impact factor: 4.742

6.  Methanol extract of Ocimum gratissimum protects murine peritoneal macrophages from nicotine toxicity by decreasing free radical generation, lipid and protein damage and enhances antioxidant protection.

Authors:  Santanu Kar Mahapatra; Subhankari Prasad Chakraborty; Subhasis Das; Somenath Roy
Journal:  Oxid Med Cell Longev       Date:  2009 Sep-Oct       Impact factor: 6.543

7.  Ocimum gratissimum Aqueous Extract Protects H9c2 Myocardiac Cells from H(2)O(2)-Induced Cell Apoptosis through Akt Signalling.

Authors:  Mu-Jang Lee; Han-Min Chen; Bor-Show Tzang; Chiu-Wen Lin; Chau-Jong Wang; Jer-Yuh Liu; Shao-Hsuan Kao
Journal:  Evid Based Complement Alternat Med       Date:  2010-08-30       Impact factor: 2.629

8.  Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.

Authors:  Anita Vasudevan; Yingjie Yu; Sanjeev Banerjee; James Woods; Lulu Farhana; Sindhu G Rajendra; Aamil Patel; Gregory Dyson; Edi Levi; Krishna Rao Maddipati; Adhip P N Majumdar; Pratima Nangia-Makker
Journal:  Cancer Prev Res (Phila)       Date:  2014-09-05

9.  Ocimum gratissimum Aqueous Extract Induces Apoptotic Signalling in Lung Adenocarcinoma Cell A549.

Authors:  Han-Min Chen; Mu-Jang Lee; Cheng-Yi Kuo; Pei-Lin Tsai; Jer-Yuh Liu; Shao-Hsuan Kao
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-26       Impact factor: 2.629

10.  Herbal Supplement Ameliorates Cardiac Hypertrophy in Rats with CCl(4)-Induced Liver Cirrhosis.

Authors:  Ping-Chun Li; Yung-Wei Chiu; Yueh-Min Lin; Cecilia Hsuan Day; Guang-Yuh Hwang; Peiying Pai; Fuu-Jen Tsai; Chang-Hai Tsai; Yu-Chun Kuo; Hsiao-Chuan Chang; Jer-Yuh Liu; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.